Trial Profile
Clinical Trials Insight: 700015938
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Oct 2006
Price :
$35
*
At a glance
- Drugs Brivudine (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors SciClone Pharmaceuticals
- 09 Oct 2006 New trial record.